Nanobacterie (www.nanobacterie.fr) is a Medtech, which was created in 2008. It develops a cancer treatment using natural iron oxide nano-minerals, called magnetosomes, which are introduced to tumors and heated using various excitation sources (laser, ultrasound, magnetic field). We have demonstrated the full efficacy of our treatment on mice bearing several different types of tumors (prostate, glioblastoma, breast tumors). It leads to full tumor disappearance in all treated mice without tumor regrowth at 6 months. It is also safe, which is due to its moderate heating conditions and to the use of natural nanoparticles.
Nanobacterie’s treatment presents the following advantages: i) it does not require general anesthesia and the operation theatre, ii) it is characterized by a large benefit/risk ratio, iii) it is of low cost of fabrication.
Nanobacterie has published > 40 scientific papers describing its activity and has patented its treatment methods as well as its nanoparticles (access to articles/patents provided).
The company employs 5 researchers, has trained several PhD and Master students through to their diploma, thanks to the CIFRE program supported by the ANRT, and works in collaboration with several academic laboratories in France and Switzerland, as well as a urologist specialized in prostate tumor treatment at Montsouris institute.
Nanobacterie’s R&D laboratory is located within the campus of Paris Saclay University, which is one of the largest European scientific campuses. Nanobacterie's R&D has been supported in France by the Tax research credits, grants/loans awarded by BPI, and private investors.
Nanobacterie has built a strong scientific relationship with the University of Zurich and Bioark, thanks to the support from Eurostars, BPI, Innosuisse, the Nomis foundation, and the Canton of Valais, leading to the creation of a Swiss subsidiary in August 2022, called AlphaOnco Swiss SA.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 36, Boulevard Flandrin, Paris,île-De-France 75116,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nanobacterie.fr
- Keywords
- Nanomedecine, Biotechnology, Oncology, Nanoparticles, Magnetosomes, Bioproduction, Biocompatibility, Nanotechnology, Magnetotactic bacteria production, Formulation Nanoparticles.
- HQ
- Paris, Île-de-France
Alphaonco Questions
Alphaonco's website is http://www.nanobacterie.fr
Alphaonco's LinkedIn profile is https://fr.linkedin.com/company/alphanonco
Alphaonco has
2 employees.
View email and phone details for 2
employees at Alphaonco.
Alphaonco's industry is
Biotechnology Research
Alphaonco's top competitors are
Karcinolys,
Spikimm,
Adipophyt,
Nanobacterie,
Oxiproteomics,
Brainvectis,
Imescia,
Alphaonco Swiss Sa,
Dillygence,
Curadigm.
Alphaonco's categories are Biotechnology Research
Alphaonco's founding year is 2008
